Regulation 53
Referral needed before service provided to patients
of Healthcare Services (Nuclear Medicine Service) Regulations 2023
Subsidiary LegislationIn forceProvision 53 of 80
Regulation 53
A licensee must not perform an in vivo assay procedure on a patient who resides in Singapore unless —
(a)
the patient is referred to the licensee for the in vivo assay procedure by a medical practitioner; or
(b)
where the licensee is appointed or engaged to conduct the in vivo assay procedure on behalf of another licensee — the patient is referred to the other licensee for the in vivo assay procedure by a medical practitioner.